| Amgros 2027 2.690.b | Amgros I/S | Sandoz A/S, Accord Healthcare AB, 2care4 ApS, Orifarm Generics A/S, STADA Nordic ApS, Viatris ApS, +7 | 102,2 mio. kr. (samlet) | 27.10.2026 |
| Amgros 2027 1.604.a | Amgros I/S | Viatris ApS, Sandoz A/S, Abcur AB, Glenmark Pharmaceuticals Nordic AB, Krka Sverige AB, Teva Denmark A/S, +5 | 284,6 mio. kr. (samlet) | 27.10.2026 |
| Amgros 2027 1.1206.a | Amgros I/S | Øresund Pharma ApS, Aguettant Nordic ApS, Takeda Pharma A/S, Viatris ApS, Abacus Medicine A/S, GE Healthcare A/S, +1 | 240 mio. kr. (samlet) | 26.10.2026 |
| Amgros 2027 2.691.b | Amgros I/S | Teva Denmark A/S, Krka Sverige AB, Orifarm Generics A/S, Macure Pharma ApS, Takeda Pharma A/S, Strides Nordic ApS, +1 | 48,4 mio. kr. (samlet) | 26.10.2026 |
| Amgros 2027 2.3.b | Amgros I/S | Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Macure Pharma ApS, Accord Healthcare AB, FrostPharma AB, Zentiva Denmark ApS, Sun Pharmaceuticals Germany GmbH, +10 | 690,9 mio. kr. (samlet) | 19.10.2026 |
| Amgros 2027 1.204.a | Amgros I/S | Vifor Pharma Nordiska AB, Viatris ApS, Pharmacosmos A/S | 335 mio. kr. (samlet) | 16.10.2026 |
| Amgros 2027 1.1203.a | Amgros I/S | Navamedic AB, Hameln Pharma ApS, Macure Pharma ApS, Orifarm A/S, 2care4 ApS, Viatris ApS, +6 | 148,1 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 1.201.a | Amgros I/S | 2care4 ApS, LEO Pharma A/S, Abacus Medicine A/S, Viatris ApS, Octapharma Nordic AB, CSL Behring AB, +2 | 101,4 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 1.700.a | Amgros I/S | Macure Pharma ApS, Swedish Orphan Biovitrum AB, Orifarm Generics A/S, Recordati AB, Viatris ApS, Orifarm A/S, +9 | 419,4 mio. kr. (samlet) | 14.10.2026 |
| Amgros 2026 1.630.b | Amgros I/S | Zentiva Denmark ApS, Medical Valley Invest AB, Viatris ApS, Accord Healthcare AB, Merz Therapeutics Nordics AB | 130,6 mio. kr. (samlet) | 14.9.2026 |
| Amgros 2026 1.730.b | Amgros I/S | Viatris ApS, STADA Nordic ApS, Zentiva Denmark ApS, Accord Healthcare AB, Boehringer Ingelheim Danmark A/S | 499,6 mio. kr. (samlet) | 15.5.2026 |
| Amgros 2026 1.170.b | Amgros I/S | STADA Nordic ApS, Newbury Pharmaceuticals AB, Zentiva Denmark ApS, Accord Healthcare AB, Sandoz A/S, Viatris ApS, +1 | 896 mio. kr. (samlet) | 17.2.2026 |
| Amgros 2026 1.1454.b | Amgros I/S | Newbury Pharmaceuticals AB, Glenmark Pharmaceuticals Nordic AB, Zentiva Denmark ApS, Accord Healthcare AB, Viatris ApS | 30 mio. kr. (samlet) | 28.1.2026 |
| Amgros 2026 2.1305.a | Amgros I/S | Abacus Medicine A/S, Viatris ApS | 13,2 mio. kr. (samlet) | 26.1.2026 |
| Amgros 2026 1.13.b | Amgros I/S | Aspen Pharma Ireland Limited, Viatris ApS | 21,3 mio. kr. (samlet) | 25.11.2025 |
| Amgros 2026 1.842.b | Amgros I/S | Novartis Healthcare A/S, Glenmark Pharmaceuticals Nordic AB, Teva Denmark A/S, Zentiva Denmark ApS, Viatris ApS | 57 mio. kr. (samlet) | 14.11.2025 |
| Amgros 2026 1.1452.a | Amgros I/S | STADA Nordic ApS, Pfizer ApS, Recordati AB, Viatris ApS, Ipsen AB | 1,4 mia. kr. (samlet) | 4.11.2025 |
| Amgros 2026 2.1390.b | Amgros I/S | Viatris ApS, EQL Pharma AB, Orifarm Generics A/S, Orion Pharma A/S, 2care4 ApS, Teva Denmark A/S, +6 | 23,9 mio. kr. (samlet) | 3.11.2025 |
| Amgros 2026 2.1303.b | Amgros I/S | Paranova Danmark A/S, Orifarm A/S, 2care4 Generics ApS, EQL Pharma AB, Viatris ApS | 4,1 mio. kr. (samlet) | 3.11.2025 |